PHILADELPHIA, Pa. , Feb. 8, 2024 /PRNewswire/ — A securities fraud lawsuit has been filed against BioVie Inc. (“BioVie” or the “Company”) (NASDAQ: BIVI). The lawsuit is captioned Olmstead v. BioVie Inc. et al., No. 3:24-cv-00035 (D. Nev.), and is filed on behalf of purchasers of BioVie’s…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.